Nexi Valuation

Is N0XA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of N0XA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: N0XA (€5.75) is trading above our estimate of fair value (€4.42)

Significantly Below Fair Value: N0XA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for N0XA?

Other financial metrics that can be useful for relative valuation.

N0XA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.7x
Enterprise Value/EBITDA12.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does N0XA's PS Ratio compare to its peers?

The above table shows the PS ratio for N0XA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.1x
ARLN Aareal Bank
2.3x10.5%€2.0b
DWS DWS Group GmbH KGaA
1.7x-4.5%€6.7b
ARLN Aareal Bank
2.7xn/a€2.2b
HYQ Hypoport
5.5x13.4%€2.0b
N0XA Nexi
1.3x-13.6%€7.6b

Price-To-Sales vs Peers: N0XA is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (3.1x).


Price to Earnings Ratio vs Industry

How does N0XA's PE Ratio compare vs other companies in the DE Diversified Financial Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.2%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.2%
n/an/an/a
No more companies

Price-To-Sales vs Industry: N0XA is good value based on its Price-To-Sales Ratio (1.3x) compared to the European Diversified Financial industry average (1.9x).


Price to Sales Ratio vs Fair Ratio

What is N0XA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

N0XA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.3x
Fair PS Ratio2.5x

Price-To-Sales vs Fair Ratio: N0XA is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (2.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst N0XA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€5.75
€8.00
+39.0%
16.3%€10.40€5.50n/a18
Jun ’25€6.10
€7.98
+30.9%
15.9%€10.40€5.50n/a19
May ’25€5.54
€7.90
+42.6%
16.3%€10.40€5.50n/a19
Apr ’25€5.86
€8.14
+38.9%
15.0%€10.40€5.50n/a19
Mar ’25€6.74
€8.67
+28.7%
22.7%€15.80€6.30n/a19
Feb ’25€7.06
€8.80
+24.7%
22.6%€15.80€6.30n/a19
Jan ’25€7.34
€8.72
+18.7%
22.6%€15.80€6.30n/a19
Dec ’24€7.17
€8.80
+22.6%
22.4%€15.80€6.30n/a19
Nov ’24€5.44
€9.21
+69.3%
24.4%€15.80€6.30n/a19
Oct ’24€5.90
€10.80
+83.1%
18.2%€15.80€7.60n/a18
Sep ’24€6.57
€10.98
+67.1%
17.6%€15.80€7.60n/a19
Aug ’24€7.41
€11.01
+48.6%
17.8%€15.80€7.60n/a19
Jul ’24€6.95
€11.08
+59.5%
17.9%€15.80€7.60n/a18
Jun ’24€7.29
€11.08
+52.0%
17.9%€15.80€7.60€6.1018
May ’24€7.60
€11.13
+46.3%
17.7%€15.80€7.60€5.5418
Apr ’24€7.29
€11.31
+55.1%
15.9%€15.80€8.60€5.8618
Mar ’24€7.57
€11.65
+53.8%
14.4%€15.80€8.60€6.7418
Feb ’24€7.98
€11.62
+45.7%
16.4%€15.80€8.60€7.0619
Jan ’24€7.49
€12.19
+62.9%
16.0%€15.80€8.60€7.3419
Dec ’23€8.41
€12.38
+47.3%
14.8%€15.80€9.80€7.1718
Nov ’23€8.68
€12.56
+44.8%
18.8%€18.00€9.60€5.4417
Oct ’23€8.00
€12.64
+58.0%
19.8%€18.00€9.60€5.9017
Sep ’23€8.10
€13.71
+69.2%
27.7%€26.00€9.50€6.5718
Aug ’23€8.81
€13.74
+56.0%
27.4%€26.00€9.50€7.4118
Jul ’23€7.84
€15.68
+100.1%
28.7%€26.00€8.60€6.9518
Jun ’23€9.40
€16.49
+75.4%
25.1%€26.00€10.00€7.2918

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.